erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Imshenetskaia VF [The drug resistance of staphylococci isolated in neurosurgical clinical practice]. 1974 Antibiotiki pmid:4618746
Veselov AIa and Plotnikova NI [The sensitivity of salmonella to antibiotics]. 1974 Antibiotiki pmid:4618752
Sytina VV et al. [The relationship between the antibiotic resistance and serologic type of staphylococci]. 1974 Antibiotiki pmid:4618760
Griaznova NS et al. [Cooperative functioning of 2 systems of protection against its own antibiotic in Str. erythreus 1571, a superproducer of erythromycin]. 1982 Antibiotiki pmid:7065644
Sukhodol'skaia AE and ChaÄ­kovskaia VL [The effect of combinations of antibacterial preparations on resistant strains of pyelonephritis agents]. 1974 Antibiotiki pmid:4618771
Bukharovich AM [Microbiological substantiation of the use of erycycline in the therapy of chronic pyoderma]. 1982 Antibiotiki pmid:7092196
Zueva VS et al. [Transmission of extrachromosomal drug resistance in staphylococci present in animals and the effect of neomycin on this process]. 1970 Antibiotiki pmid:5489278
Blinov NO and Khokhlov AS [Paper chromatography and electrophoresis in the study of the transformation of antibiotics in the human and animal body]. 1967 Antibiotiki pmid:4874768
Maichuk IuF [Antibiotics in polyvinyl alcohol film for treatment of infectious eye diseases]. 1967 Antibiotiki pmid:4874770
Listvinova SN et al. [Action of erythromycin on its own producer in cultivation on broth media]. 1983 Antibiotiki pmid:6859818
Belousova II et al. [Effect of erythromycin and its combination with protamine hydrochloride on binding of C 14-chloramphenicol with ribosomes of E.coli]. 1973 Antibiotiki pmid:4590904
PokrovskiÄ­ VI and Timina VP [Antibiotics in the clinical aspects of infectious diseases]. 1974 Antibiotiki pmid:4499238
Ermol'eva ZV and Kereselidze TS [Prevention of cholera by antibiotics]. 1971 Antibiotiki pmid:4255832
Imshenetskaia VF [Correlation between levels of staphylococcal resistance to antibiotics and amounts used in clinical practice]. 1974 Antibiotiki pmid:4499631
Unich NK [Sensitivity of the microbial flora isolated from ill young children with acute gastrointestinal diseases to antibiotics, chemical preparations and polyvalent proteus phage]. 1974 Antibiotiki pmid:4377086
Kocherovskaia EIu and Kalabukhova NF [Selection of antibiotic inhibitors of the growth of extraneous microflora in elective nutrient media]. 1974 Antibiotiki pmid:4377090
Lobanova VV et al. [The use of corn meal in the biosynthesis of erythromycin]. 1966 Antibiotiki pmid:5984183
Bass TM [Effect of reaction of medium and anaerobic conditions on the action of oletetrine (sigmamycin) and the combination of erythromycin with tetracycline]. 1970 Antibiotiki pmid:5479696
Shestialtynova IS [Effect of tetracycline in combination with other antibiotics on causative agents of purulent infection]. 1971 Antibiotiki pmid:4995503
Shtol'ts MG et al. [Erythromycin polymorphism]. 1966 Antibiotiki pmid:5988109
Belizhenko GG [Effect of trypsin on the activity of tetracycline, erythromycin and levomycetin]. 1975 Antibiotiki pmid:1180534
Voropaeva SD [Multiple resistance of staphylococci, isolated from the patients]. 1969 Antibiotiki pmid:5192737
Brinberg SL et al. [Dependence of erythromycin biosynthesis on the active acidity of the medium]. 1976 Antibiotiki pmid:11737
Lobanova W and Brinberg SL [Study of the respiration of erythromycin producer]. 1971 Antibiotiki pmid:5139444
Lobanova VV et al. [Physiological study of the erythromycin-producing actinomyces erythreus strain IAE-1-EFU]. 1970 Antibiotiki pmid:5458631
KORCHAGIN VB et al. [A colorimetric method for the determination of erythromycin]. 1961 Antibiotiki pmid:13753122
SAZYKIN IuO and BORISOVA GN [Effect of bacteriostatic antibiotics on the synthesis of proteins and nucleic acids in the cells of Staphylococcus aureus]. 1962 Antibiotiki pmid:13976458
SAZYKIN IuO and BORISOVA GN [EFFECT OF SPECIFIC INHIBITORS ON THE SYNTHESIS OF RIBONUCLEIC ACID IN THE BACTERIAL CELL DISSOCIATED WITH THE SYNTHESIS OF PROTEINS BY BACTERIOSTATIC ANTIBIOTICS]. 1963 Antibiotiki pmid:14072475
BRINBERG SL [Effect of phosphorus on erythromycin biosynthesis]. 1962 Antibiotiki pmid:13873106
SHNEERGSON AN [Effect of antibiotics from the erythromycin group on some biological properties of diphtherial bacilli]. 1961 Antibiotiki pmid:13912187
Iurenev PN et al. [Complications from antibiotic therapy]. 1975 Antibiotiki pmid:1211892
Belizhenko GG et al. [Study of the joint action of lysozyme and the antibiotics, tetracycline, erythromycin and levomycetin, on Staphylococcus aureus]. 1975 Antibiotiki pmid:1211905
Tereshin IM [Mechanism of action of mitomycin C on genetic transformation of hemolytic Streptococci]. 1969 Antibiotiki pmid:4982962
Serebrennikova II [Correlation between sensitivity of diphtheria bacteria to antibiotics and the presence of fungi of the Candida order]. 1969 Antibiotiki pmid:4982964
Brikman DI and Zakhlebnaia OD [Sensitivity of various races of the tularemia microbe to erythromycin, oleandomycin and polymyxin]. 1976 Antibiotiki pmid:179462
Gauze GF [Current methods of determination of the sensitivity of bacteria to antibiotics and their significance for rational antibiotic therapy]. 1969 Antibiotiki pmid:4311307
Imshenetskaia VF [Erythromycin penetration into the cerebrospinal fluid of patients]. 1976 Antibiotiki pmid:1020930
MUSILEK V and SEVCIK V [Effect of an acetate, formate and propionate on the biosynthesis of erythromycin]. 1961 Antibiotiki pmid:14477556
Lopatin AI and Kolesnikov NP [Treatment of non-gonorrheal urethritis in males with rectal administration of antibiotics]. 1973 Antibiotiki pmid:4762747
Tumanian MA and Izvekova AV [The effectiveness of treating infectious complications of radiation sickness with antibiotics]. 1974 Antibiotiki pmid:4462452
Kuzina ZA and Tereshin IM [Sedimentation properties of Salmonella pullorum ribosomes and the effect of antibiotics on them]. 1974 Antibiotiki pmid:4463881
Abkarovich GF [The relationship between the effectiveness of complex antibacterial therapy of acute pneumonia and calculation of the sensitivity of sputum microflora]. 1974 Antibiotiki pmid:4463888
MAICHUK IuF [EXPERIMENTAL STUDIES ON ERYTHROMYCIN ASCORBATE]. 1964 Antibiotiki pmid:14232881
SHERSHEVSKAIA RS [APROPOS OF THE ANTIGENIC VARIABILITY OF DYSENTERIAL BACTERIA UNDER THE INFLUENCE OF ANTIBIOTICS]. 1964 Antibiotiki pmid:14232884
Proskurov VA [Antibiotic sensitivity and dependence between pathogenic properties of staphylococci and antibiotic resistance]. 1972 Antibiotiki pmid:4483686
Ivanitskaia LP and Manafova NA [Study of sensitivity to antibiotics in cultures of Anacystis nidulans and Chlorella sp. in relation to their possible use as tests in selection of new biologically active compounds from Actinomycetes]. 1968 Antibiotiki pmid:4180805
MartinevskiÄ­ IL and Stogova AG [Sensitivity to antibiotics of different representatives of family Yersinia]. 1969 Antibiotiki pmid:4181311
Plakunov VK and Myl'nikova SI [2 mechanisms of tetracycline resistance in bacteria]. 1976 Antibiotiki pmid:793507
Chernomordik AB [Synergistic action of antibiotics on Bacillus pyocianaeus]. 1967 Antibiotiki pmid:4300088
Tereshin IM [Study of the mechanism of action of actinomycin C on genetic transformation of Streptococcus haemolyticus]. 1969 Antibiotiki pmid:4181312
Ermol'eva ZV et al. [Sensitivity of cholera vibrios to antibiotics]. 1969 Antibiotiki pmid:4182157
Veselov AIa and Plotnikova NI [Species composition of excreted Shigella and the characteristic of their sensitivity to antibiotics during 11 years (1959-1969)]. 1971 Antibiotiki pmid:4934035
Zadvorniak PV and BronshteÄ­n RE [Microflora of lungs in pneumonias of infants and its sensitivity to antibiotics]. 1969 Antibiotiki pmid:4391893
Sobolev VR et al. [Comparative study of the sensitivity to different antibiotics of Staphylococci isolated from patients and attendants]. 1971 Antibiotiki pmid:4934037
Voropaeva SD et al. [Transduction transmission of the extrachromosomal markers of antibiotic resistance in staphylococcal populations]. 1976 Antibiotiki pmid:133633
Kalabukhova NF [Effect of ampicillin and different combination of antibiotics in relation to Staphylococci isolated from patients with enterocolitis]. 1969 Antibiotiki pmid:4901555
IAKOBSON LM et al. [Attempted international standardization of erythromycin]. 1958 Mar-Apr Antibiotiki (Mosc) pmid:24544839
Calvert H et al. Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer. 2014 Anticancer Drugs pmid:24637575
Ohkura K et al. Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket. 2009 Anticancer Res. pmid:19414330
Kiso S et al. Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats. 2000 Sep-Oct Anticancer Res. pmid:11062690
Gunics G et al. Enhanced antibacterial effect of erythromycin in the presence of 3,5-dibenzoyl-1,4-dihydropyridines. 2001 Jan-Feb Anticancer Res. pmid:11299745
OSWALD EJ et al. IN VITRO ANTISTAPHYLOCOCCAL EFFECTS OF ERYTHROMYCIN COMBINED WITH SEMISYNTHETIC PENICILLINS. 1964 Antimicrob Agents Chemother (Bethesda) pmid:14287966
GUZE LB and KALMANSON GM EFFECT OF ERYTHROMYCIN ON IN VIVO "PROTOPLAST" INFECTION. 1964 Antimicrob Agents Chemother (Bethesda) pmid:14288026
Garrison DW et al. Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin. 1967 Antimicrob Agents Chemother (Bethesda) pmid:5596165
Duncan IB Development of lincomycin resistance by staphylococci. 1967 Antimicrob Agents Chemother (Bethesda) pmid:5596212
TAUBMAN SB et al. EFFECT OF ERYTHROMYCIN ON PROTEIN BIOSYNTHESIS IN BACILLUS SUBTILIS. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14274930
SELL SH and SANDERS RS THERAPY WITH ERYTHROMYCIN ESTOLATE FOR OTITIS MEDIA ASSOCIATED WITH HAEMOPHILUS INFLUENZAE INFECTION. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14274999
MOFFETT HL et al. ERYTHROMYCIN ESTOLATE AND PHENOXYMETHYL PENICILLIN IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14275000
Spizek J et al. Biogenetic relationship of the erythromycins and the lactone of erythromycin B. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883418
Grady JE and Stern KF Penetration of lincomycin into bone. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883427
Rasch JR and Mogabgab WJ Therapeutic effect of erythromycin on Mycoplasma pneumoniae pneumonia. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883484
Whaley HA et al. LL-A0341 A and B, new antibiotics. I. Isolation and characterization. 1966 Antimicrob Agents Chemother (Bethesda) pmid:5985292
Wilhelm JM et al. Interaction of antibiotics with ribosomes: structure-function relationships and a possible common mechanism for the antibacterial action of the macrolides and lincomycin. 1967 Antimicrob Agents Chemother (Bethesda) pmid:4970204
Perun TJ et al. Conformation of mactolide antibiotics. IV. Nuclear magnetic resonance, circular dichroism, and chemical studies of erythromycin derivatives. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396476
Jones PH et al. Chemical modifications of erythromycin antibiotics. II. Synthesis of 4'-hydroxyerythromycin A. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396478
Zinner SH et al. Erythromycin plus alkalinization in treatment of urinary infections. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396518
Weinstein MJ et al. Preliminary studies on megalomicin, a new Micromonospora-produced macrolide antibiotic complex. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735370
Paterson PY and Madden GM Occurrence and erythromycin susceptibility of penicillin-resistant Viridans streptococci in rheumatic fever patients on oral penicillin prophylaxis. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735376
McGehee RF R et al. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735385
Wick WE and Mallett GE New analysis for the therapeutic efficacy opropionyl erythromycin and erythromycin base. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735386
Kawamata J and Nakajima K Mode of action of colistin. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5327517
Boyd RJ and Godzeski CW Selected antibiotic effects on the L-phase of Protus mirabilis in tissue culture. 1970 Antimicrob Agents Chemother (Bethesda) pmid:5521355
Doern GV et al. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. 1996 Antimicrob. Agents Chemother. pmid:8849246
Rukayadi Y et al. In vitro activities of panduratin A against clinical Staphylococcus strains. 2009 Antimicrob. Agents Chemother. pmid:19651906
Nielsen EI et al. Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model. 2011 Antimicrob. Agents Chemother. pmid:21282424
Greenberg RN et al. Susceptibility of Shigella species to erythromycin. 1982 Antimicrob. Agents Chemother. pmid:7073270
Mendes RE et al. In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates. 2010 Antimicrob. Agents Chemother. pmid:20385851
Tateda K et al. Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa. 1993 Antimicrob. Agents Chemother. pmid:8494362
Shortridge VD et al. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci. 2002 Antimicrob. Agents Chemother. pmid:11850262
Ardanuy C et al. Increase of the M phenotype among erythromycin-resistant Streptococcus pneumoniae isolates from Spain related to the serotype 14 variant of the Spain9V-3 clone. 2006 Antimicrob. Agents Chemother. pmid:16940119
Patamasucon P et al. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. 1981 Antimicrob. Agents Chemother. pmid:6975059
Dreier J et al. Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes. 2007 Antimicrob. Agents Chemother. pmid:17923495
Edelstein PH and Edelstein MA In vitro activity of Ro 23-9424 against clinical isolates of Legionella species. 1992 Antimicrob. Agents Chemother. pmid:1489206
Waites KB et al. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. 1991 Antimicrob. Agents Chemother. pmid:1929260
Basset P et al. Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area. 2010 Antimicrob. Agents Chemother. pmid:20713672
Frank MO et al. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. 1992 Antimicrob. Agents Chemother. pmid:1336337
Stadler C and Teuber M The macrolide efflux genetic assembly of Streptococcus pneumoniae is present in erythromycin-resistant Streptococcus salivarius. 2002 Antimicrob. Agents Chemother. pmid:12384396
Ikebe T et al. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections. 2005 Antimicrob. Agents Chemother. pmid:15673769
Edelstein PH et al. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia. 1996 Antimicrob. Agents Chemother. pmid:8834872
Zhang T et al. Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains. 2010 Antimicrob. Agents Chemother. pmid:20421401